Page last updated: 2024-12-08
spirobrassinin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
spirobrassinin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 188830 |
CHEMBL ID | 4539060 |
MeSH ID | M0376044 |
Synonyms (7)
Synonym |
---|
113866-40-3 |
(-)-spirobrassinin |
spirobrassinin |
(s)-(-)-spirobrassinin |
spirobrassinine |
DTXSID60904136 |
CHEMBL4539060 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (2)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1617009 | Neuroprotective activity in rat C6 cells assessed as NGF secretion at 20 uM incubated for 24 hrs by ELISA relative to control | 2019 | Journal of natural products, 11-22, Volume: 82, Issue:11 | Thiohydantoin and Hydantoin Derivatives from the Roots of |
AID1617010 | Cytotoxicity against rat C6 cells assessed as cell viability at 20 uM incubated for 24 hrs by MTT assay relative to control | 2019 | Journal of natural products, 11-22, Volume: 82, Issue:11 | Thiohydantoin and Hydantoin Derivatives from the Roots of |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (63.64) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (9.09%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (90.91%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |